These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23227530)

  • 1. [Is liver biopsy the gold standard for assessment of liver fibrosis?].
    Hu XQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):568-70. PubMed ID: 23227530
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
    Poynard T; de Ledinghen V; Zarski JP; Stanciu C; Munteanu M; Vergniol J; France J; Trifan A; Le Naour G; Vaillant JC; Ratziu V; Charlotte F;
    J Hepatol; 2012 Mar; 56(3):541-8. PubMed ID: 21889468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transient elastography for diagnosing liver fibrosis].
    Mössner BK; Pedersen C; Christensen PB
    Ugeskr Laeger; 2008 Aug; 170(33):2453-6. PubMed ID: 18761829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis.
    Fung J; Lai CL; Chan SC; But D; Seto WK; Cheng C; Wong DK; Lo CM; Fan ST; Yuen MF
    Am J Gastroenterol; 2010 May; 105(5):1116-22. PubMed ID: 19920809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of fibrosis and cirrhosis in liver biopsies: an update.
    Germani G; Hytiroglou P; Fotiadu A; Burroughs AK; Dhillon AP
    Semin Liver Dis; 2011 Feb; 31(1):82-90. PubMed ID: 21344353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of liver biopsy in the assessment of hepatic fibrosis--its utility and limitations].
    Jin SY
    Korean J Hepatol; 2007 Jun; 13(2):138-45. PubMed ID: 17585187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of FibroScan in the diagnosis of liver fibrosis].
    Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):571-2. PubMed ID: 23227531
    [No Abstract]   [Full Text] [Related]  

  • 10. Sampling variability of liver fibrosis in chronic hepatitis C.
    Bedossa P; Dargère D; Paradis V
    Hepatology; 2003 Dec; 38(6):1449-57. PubMed ID: 14647056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of liver fibrosis.
    Martínez SM; Crespo G; Navasa M; Forns X
    Hepatology; 2011 Jan; 53(1):325-35. PubMed ID: 21254180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive methods to assess liver disease in patients with hepatitis B or C.
    Castera L
    Gastroenterology; 2012 May; 142(6):1293-1302.e4. PubMed ID: 22537436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accuracy of sonography in the diagnosis of diffuse liver parenchymal diseases--comparison of sonography and liver histology].
    Steinmaurer HJ; Jirak P; Walchshofer J; Clodi PH
    Ultraschall Med; 1984 Jun; 5(3):98-103. PubMed ID: 6474150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.
    Castera L
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):291-303. PubMed ID: 21497746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index.
    Petta S; Di Marco V; Cammà C; Butera G; Cabibi D; Craxì A
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1350-60. PubMed ID: 21517924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver biopsy remains the gold standard for evaluation of chronic hepatitis and fibrosis.
    Saleh HA; Abu-Rashed AH
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):425-6. PubMed ID: 18193125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.